US BANCORP \DE\ - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 61 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,063
+80.1%
10,2800.0%0.00%
Q2 2023$1,701
-83.0%
10,2800.0%0.00%
Q1 2023$10,033
-6.2%
10,2800.0%0.00%
Q4 2022$10,691
-10.9%
10,2800.0%0.00%
Q3 2022$12,000
-36.8%
10,2800.0%0.00%
Q2 2022$19,000
-38.7%
10,2800.0%0.00%
Q1 2022$31,000
-20.5%
10,2800.0%0.00%
Q4 2021$39,000
-26.4%
10,2800.0%0.00%
Q3 2021$53,000
+35.9%
10,2800.0%0.00%
Q2 2021$39,000
+50.0%
10,2800.0%0.00%
Q1 2021$26,0000.0%10,2800.0%0.00%
Q4 2020$26,000
+23.8%
10,2800.0%0.00%
Q3 2020$21,000
-34.4%
10,2800.0%0.00%
Q2 2020$32,000
+39.1%
10,2800.0%0.00%
Q1 2020$23,000
-37.8%
10,2800.0%0.00%
Q4 2019$37,000
+5.7%
10,2800.0%0.00%
Q3 2019$35,000
-27.1%
10,2800.0%0.00%
Q2 2019$48,000
+41.2%
10,2800.0%0.00%
Q1 2019$34,000
+25.9%
10,2800.0%0.00%
Q4 2018$27,000
-53.4%
10,2800.0%0.00%
Q3 2018$58,000
+11.5%
10,2800.0%0.00%
Q2 2018$52,000
-25.7%
10,2800.0%0.00%
Q1 2018$70,000
-10.3%
10,2800.0%0.00%
Q4 2017$78,000
+32.2%
10,2800.0%0.00%
Q3 2017$59,00010,2800.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders